Correction to: Blood Cancer Journal https://doi.org/10.1038/s41408-025-01279-9, published online 24 April 2025
In this article, the figure legend of Fig. 3 was given erroneously. Specifically, in the legend the colors representing CR and PR have been interchanged.
In the figure, the green bars correctly represent CR, and the blue bars correctly represent PR.
However, in the legend, the boxagainst CR has the blue color, and the box adjacent to PR has green color.
The correction needed is to change the colors of these boxes so that the box next to CR shows the green color and the box next to PR shows the blue color.
The original article has been updated.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Narula, G., Keerthivasagam, S., Jain, H. et al. Correction: Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study. Blood Cancer J. 15, 98 (2025). https://doi.org/10.1038/s41408-025-01308-7
Published:
DOI: https://doi.org/10.1038/s41408-025-01308-7
